[EN] PROCESS FOR THE PREPARATION OF RIDINILAZOLE AND CRYSTALLINE FORMS THEREOF<br/>[FR] PROCÉDÉ DE PRÉPARATION DE RIDINILAZOLE ET DE FORMES CRISTALLINES DE CELUI-CI
申请人:SUMMIT OXFORD LTD
公开号:WO2021009514A1
公开(公告)日:2021-01-21
Described are processes for the preparation of 2,2'-di(pyridin-4-yl)-1H,1'H-5,5'- bibenzo[d]imidazole (which may also be known as 5,5'bis-[2-(4-pyridinyl)-1H- benzimidazole]), referenced herein by the INN name ridinilazole, and pharmaceutically acceptable derivatives, salts, hydrates, solvates, complexes, bioisosteres, metabolites or prodrugs thereof. The invention also relates to various compositions of purified ridinilazole, to various crystalline forms of ridinilazole, to processes for their preparation and to related pharmaceutical preparations and uses thereof (including their medical use and their use in the efficient large-scale synthesis of ridinilazole).
介绍了制备2,2'-二(吡啶-4-基)-1H,1'H-5,5'-双苯并[d]咪唑(也可以被称为5,5'-双-[2-(4-吡啶基)-1H-苯并咪唑])的过程,该化合物在此处以国际非专利药品名称ridinilazole命名,以及其药学上可接受的衍生物、盐、水合物、溶剂化物、配合物、生物等效物、代谢物或前药。本发明还涉及纯化ridinilazole的各种组合物、ridinilazole的各种晶体形式、其制备过程以及相关的制药制剂和用途(包括其医学用途和在ridinilazole的高效大规模合成中的应用)。